Debasish Roychowdhury

Dr. Roychowdhury is a hematologist/oncologist with over a decade of patient care, academic research and teaching experience as well as over 15 years of pharmaceutical industry and senior management experience. He is a leader in the pharmaceutical industry across multiple functional and cross-functional areas, regions and matrices, including – all stages of R&D, regulatory, commercial operations and medical affairs, market access, business development and alliance management. During his career in the top 10 pharmaceutical companies, Dr. Roychowdhury was the Senior VP and Head of the Global Oncology Division at Sanofi. Prior to that, he served as the VP for Clinical Development at GlaxoSmithKline and directed the Oncology global regulatory group at Eli Lilly and Company. Among many other achievements, Debasish career includes 9 drug approvals in the U.S. and in Europe, the establishment of Sanofi’s Oncology Division (notably Genzyme’s integration), founding Partner Therapeutics and successfully supporting biotech companies (notably Seragon Pharmaceuticals sale to Roche/Genentech). Debasish serves as non-executive boardmember of Aelin Therapeutics.